Deadline for chief plaintiffs to apply: December 28, 2026. Investors who purchased Tenax Therapeutics (Nasdaq ticker: TENX) securities between November 13, 2023, and August 7, 2026, may be eligible to recover their losses.
New York, October 30, 2026 / PRNewswire / -- Attorney Ad -- This lawsuit is intended to represent all individuals and entities that purchased or otherwise acquired Tenax securities between November 13, 2023, and August 7, 2026 (including both dates), in order to seek damages that the defendants may be liable for due to alleged violations of federal securities laws. Relevant investors are encouraged to visit the law firm's website to join this case: bgandg.com / cases / tenax-therapeutics-inc-tenx-class-action-lawsuit.
Tenax Case Details
The indictment alleges that throughout the duration of the class action, the defendant made material false and/or misleading statements, and/or failed to disclose the following facts:
- The effectiveness of the company's leading clinical project TNX-103 is below the level implied to investors by the defendant;
- Therefore, the overall clinical, regulatory, and commercial prospects of TNX-103 have been exaggerated; as well as
- Therefore, the company's public statements during that period were materially false and misleading at all relevant time points.
Tenax What should investors do next?
A class action has been filed. If you would like to view a copy of the complaint, you may visit the law firm's website: bgandg.com / cases / tenax-therapeutics-inc-tenx-class-action-lawsuit; or contact the Peretz Bronstein attorneys or client relationship managers at Bronstein, Gewirtz & Grossman, LLC, Nathan Miller, at telephone 917-590-0911. If you have suffered losses in Tenax, you may request to be designated as the lead plaintiff by the court before December 28, 2026. Even if you are not appointed as the lead plaintiff, you are still entitled to any potential compensation.
Tenax Investors do not need to pay any upfront fees.
We, Bronstein, Gewirtz & Grossman LLC, represent the investors in the class action as risk agents. This means that we will only request the court to reimburse our out-of-pocket expenses and attorney fees, which are usually a certain percentage of the total amount recovered, if we win the case.
Why choose Bronstein, Gewirtz, Grossman, and LLC to act as proxies for the Tenax securities class action?
Bronstein, Gewirtz & Grossman, LLC is a law firm with a reputation nationwide, representing investors in securities fraud class actions and shareholder derivative lawsuits. The firm has recovered hundreds of millions of dollars for investors across the United States. For more information, please visit www.bgandg.com.
Bronstein, Gewirtz & Grossman, LLC founding partners. Peretz Bronstein stated: "Our focus is on restoring investors' capital and ensuring corporate accountability, which helps to maintain the fundamental integrity of the market."
Welcome to follow our updates on LinkedIn, X, Facebook, or Instagram.
Contact Information
Peretz Bronstein Lawyers or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC917-590-0911 | [ email protected ]Lawyer advertisement. Past results do not guarantee similar outcomes in the future.
